Evidence map›Paper›PMID 31424164›Full record

ArticleProteomics. Clinical applications2019

Management of Tamm-Horsfall Protein for Reliable Urinary Analytics.

Xiaomeng Xu, Karina Barreiro, Luca Musante, Oliver Kretz, Hanfei Lin, Hequn Zou, Tobias B Huber, Harry Holthofer

Open access · hybridAbstract read
In one paragraph

Article in Proteomics. Clinical applications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Review
  6. PeerJ · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Uromodulin and the study of urinary extracellular vesicles.Journal of extracellular biology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 6 countries.

Xiaomeng XuInstitute of Nephrology and Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Karina BarreiroInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID 0000-0003-0969-7513
Luca MusanteDivision of Nephrology, University of Virginia, Charlottesville, USA.
Oliver KretzIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Hanfei LinInstitute of Nephrology and Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Hequn ZouInstitute of Nephrology and Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Tobias B HuberIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Harry HolthoferInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Third Affiliated Hospital of Southern Medical University · CNUniversität Hamburg · DEUniversity of Helsinki · FIUniversity of Virginia · US

Funding

European Research Council 616891
6 · The paper itself

Abstract

purposeUrinary extracellular vesicles (uEVs) are a novel source of biomarkers. However, urinary Tamm-Horsfall Protein (THP; uromodulin) interferes with all vesicle isolation attempts, precipitates with normal urinary proteins, thus, representing an unwanted "contaminant" in urinary assays. Thus, the aim is to develop a simple method to manage THP efficiently. EXPERIMENTAL

designThe uEVs are isolated by hydrostatic filtration dialysis (HFD) and treated with a defined solution of urea to optimize release of uEVs from sample. Presence of uEVs is confirmed by transmission electron microscopy, Western blotting, and proteomic profiling in MS.

resultsUsing HFD with urea treatment for uEV isolation reduces sample complexity to a great extent. The novel simplified uEV isolation protocol allows comprehensive vesicle proteomics analysis and should be part of any urine analytics to release all sample constituents from THP trap. CONCLUSIONS AND CLINICAL RELEVANCE: The method brings a quick and easy protocol for THP management during uEV isolation, providing major benefits for comprehensive sample analytics.

Indexed as

AdultBiomarkersExtracellular VesiclesHumansMass SpectrometryMicroscopy, Electron, TransmissionProtein DenaturationProteomeProteomicsUreaUromodulinYoung AdultBiomarkersProteomeUreaUromodulinbiomarkermass spectrometryTamm-Horsfall proteinureaurinary extracellular vesicles

Identifiers

PMID31424164
PMCPMC6900072
OpenAlexW2969678144

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.